AURA
Price
$6.46
Change
-$0.02 (-0.31%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
402.54M
59 days until earnings call
CMVLF
Price
$2.60
Change
-$0.52 (-16.67%)
Updated
Sep 2 closing price
Capitalization
267.21M
Interact to see
Advertisement

AURA vs CMVLF

Header iconAURA vs CMVLF Comparison
Open Charts AURA vs CMVLFBanner chart's image
Aura Biosciences
Price$6.46
Change-$0.02 (-0.31%)
Volume$1.53K
Capitalization402.54M
Cellectis Romainville
Price$2.60
Change-$0.52 (-16.67%)
Volume$160
Capitalization267.21M
AURA vs CMVLF Comparison Chart in %
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. CMVLF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and CMVLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (AURA: $6.48 vs. CMVLF: $2.60)
Brand notoriety: AURA and CMVLF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 94% vs. CMVLF: 72%
Market capitalization -- AURA: $402.54M vs. CMVLF: $267.21M
AURA [@Biotechnology] is valued at $402.54M. CMVLF’s [@Biotechnology] market capitalization is $267.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 1 FA rating(s) are green whileCMVLF’s FA Score has 1 green FA rating(s).

  • AURA’s FA Score: 1 green, 4 red.
  • CMVLF’s FA Score: 1 green, 4 red.
According to our system of comparison, CMVLF is a better buy in the long-term than AURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 3 TA indicator(s) are bullish while CMVLF’s TA Score has 3 bullish TA indicator(s).

  • AURA’s TA Score: 3 bullish, 5 bearish.
  • CMVLF’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, CMVLF is a better buy in the short-term than AURA.

Price Growth

AURA (@Biotechnology) experienced а +3.51% price change this week, while CMVLF (@Biotechnology) price change was -16.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.13%. For the same industry, the average monthly price growth was +10.99%, and the average quarterly price growth was +33.00%.

Reported Earning Dates

AURA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($403M) has a higher market cap than CMVLF($267M). CMVLF YTD gains are higher at: 73.333 vs. AURA (-21.168). CMVLF has higher annual earnings (EBITDA): -30.25M vs. AURA (-107.51M). CMVLF has more cash in the bank: 196M vs. AURA (177M). AURA has less debt than CMVLF: AURA (18.1M) vs CMVLF (94.8M). CMVLF has higher revenues than AURA: CMVLF (56.3M) vs AURA (0).
AURACMVLFAURA / CMVLF
Capitalization403M267M151%
EBITDA-107.51M-30.25M355%
Gain YTD-21.16873.333-29%
P/E RatioN/AN/A-
Revenue056.3M-
Total Cash177M196M90%
Total Debt18.1M94.8M19%
FUNDAMENTALS RATINGS
CMVLF: Fundamental Ratings
CMVLF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURACMVLF
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
35%
Momentum
ODDS (%)
Bullish Trend 4 days ago
72%
Bearish Trend 4 days ago
70%
MACD
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
48%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
60%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
83%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
39%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFDSX25.220.35
+1.41%
DF Dent Small Cap Growth Investor
WIAEX40.630.11
+0.27%
Wasatch Small Cap Growth Institutional
FOSCX30.42N/A
N/A
Tributary Small Company Instl
RIVSX18.84-0.02
-0.11%
River Oak Discovery
FDFIX27.70-0.09
-0.32%
Fidelity Flex 500 Index

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with VRDN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
+0.93%
VRDN - AURA
52%
Loosely correlated
+0.43%
IDYA - AURA
49%
Loosely correlated
+5.15%
DSGN - AURA
47%
Loosely correlated
+5.56%
MGTX - AURA
46%
Loosely correlated
-0.39%
BEAM - AURA
46%
Loosely correlated
+12.62%
More

CMVLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMVLF has been loosely correlated with TENX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CMVLF jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMVLF
1D Price
Change %
CMVLF100%
N/A
TENX - CMVLF
56%
Loosely correlated
-0.08%
SBHMY - CMVLF
51%
Loosely correlated
N/A
AURA - CMVLF
30%
Poorly correlated
+0.93%
ALDX - CMVLF
23%
Poorly correlated
+0.54%
TARS - CMVLF
23%
Poorly correlated
+0.35%
More